Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-06-30T14:29:02.407Z Has data issue: false hasContentIssue false

Virtual reality and neurofeedback as a supportive approach to managing cancer symptoms for patients receiving treatment: A brief report of a feasibility trial

Published online by Cambridge University Press:  08 March 2024

Abigail J. Rolbiecki*
Affiliation:
Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Brett Froeliger
Affiliation:
School of Medicine, Department of Psychiatry, University of Missouri, Columbia, MO, USA Department of Psychological Sciences, College of Arts & Sciences, Columbia, MO, USA
Jamie Smith
Affiliation:
School of Medicine, Department of Family and Community Medicine, University of Missouri, Columbia, MO, USA
Jun Ying
Affiliation:
Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Shannon Canfield
Affiliation:
School of Medicine, Department of Family and Community Medicine, University of Missouri, Columbia, MO, USA
Kayla Posley
Affiliation:
Morehouse School of Medicine, Atlanta, GA, USA
Megan Polniak
Affiliation:
School of Medicine, Saint Louis University, Saint Louis, MO, USA
Dana Dotson
Affiliation:
Master of Biomedical Science Program, University of Missouri, Columbia, MO, USA
*
Corresponding author: Abigail Rolbiecki; Email: Abigail.rolbiecki@cuanschutz.edu

Abstract

Objectives

Managing cancer symptoms while patients receive systemic treatment remains a challenge in oncology. The use of complementary and alternative medicine (CAM) approaches like virtual reality (VR) and neurofeedback (NF) in tandem with systemic treatment might reduce symptom burden for patients. The combination of VR + NF as a CAM intervention approach is novel and understudied, particularly as it relates to supportive cancer care. The purpose of this study is to summarize our VR + NF study protocol and share preliminary results regarding study retention (across 2 treatment sessions) and preliminary impact of VR or VR + NF on patient-reported outcomes such as anxiety and pain.

Methods

We utilized a parallel arm trial design to compare preliminary impact of VR only and VR + NF on cancer symptoms among patients who are actively receiving cancer treatment.

Results

Sixty-seven percent (n = 20) of participants returned to participate in a second VR session, and the rates of return were the same between the VR groups. Patients in the VR + NF group showed improvements in anxiety after both sessions, while patients in the VR only group showed significant improvements in pain and depression after both sessions. Patients in the VR + NF group showed improved pain after session 1.

Significance of results

This study demonstrates that patients can be retained over multiple treatment sessions and that VR and NF remain promising treatment approaches with regard to impact on patient-reported outcomes like anxiety and pain.

Type
Original Article
Copyright
© The Author(s), 2024. Published by Cambridge University Press.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Balneaves, LG, Watling, CZ, Hayward, EN, et al. (2022) Addressing complementary and alternative medicine use among individuals with cancer: An integrative review and clinical practice guideline. JNCI Journal of the National Cancer Institute 114(1), 2537. doi:10.1093/jnci/djab048Google Scholar
Baños, RM, Espinoza, M, García-Palacios, A, et al. (2013) A positive psychological intervention using virtual reality for patients with advanced cancer in a hospital setting: A pilot study to assess feasibility. Supportive Care in Cancer 21(1), 263270. doi:10.1007/s00520-012-1520-xGoogle Scholar
Evenepoel, M, Haenen, V, De Baerdemaecker, T, et al. (2022) Pain prevalence during cancer treatment: A systematic review and meta-analysis. Journal of Pain and Symptom Management 63(3), e317e335. doi:10.1016/j.jpainsymman.2021.09.011Google Scholar
Garland, EL, Froeliger, B, Zeidan, F, et al. (2013) The downward spiral of chronic pain, prescription opioid misuse, and addiction: Cognitive, affective, and neuropsychopharmacologic pathways. Neuroscience and Biobehavioral Reviews 37(10 Pt 2), 25972607. doi:10.1016/j.neubiorev.2013.08.006Google Scholar
Li, X-M, Xiao, W-H, Yang, P, et al. (2017) Psychological distress and cancer pain: Results from a controlled cross-sectional survey in China. Scientific Reports 7(1), . doi:10.1038/srep39397Google Scholar
Richardson, LA and Jones, GW (2009) A review of the reliability and validity of the Edmonton Symptom Assessment System. Current Oncology (Toronto, Ont.) 16(1), . doi:10.3747/co.v16i1.261Google Scholar
Rolbiecki, AJ, Craig, K, Megan, P, et al. (2023a) Virtual reality and neurofeedback for management of cancer symptoms: A feasibility pilot. American Journal of Hospice and Palliative Medicine 40(3), 291298. doi:10.1177/10499091221109900Google Scholar
Rolbiecki, AJ, Govindarajan, A and Froeliger, B (2023b) Immersive virtual reality and neurofeedback for the management of cancer symptoms during treatment. Supportive Care in Cancer 31(8), . doi:10.1007/s00520-023-07957-3Google Scholar
Siegel, RL, Miller, KD, Fuchs, HE, et al. (2022) Cancer statistics, 2022. CA: A Cancer Journal for Clinicians 72(1), 733. doi:10.3322/caac.21708Google Scholar
Tarrant, J, Viczko, J and Cope, H (2018) Virtual reality for anxiety reduction demonstrated by quantitative EEG: A pilot study. Frontiers in Psychology 9, . doi:10.3389/fpsyg.2018.01280CrossRefGoogle ScholarPubMed
Trambaiolli, LR, Kohl, SH, Linden, DEJ, et al. (2021) Neurofeedback training in major depressive disorder: A systematic review of clinical efficacy, study quality and reporting practices. Neuroscience and Biobehavioral Reviews 125, 3356. doi:10.1016/j.neubiorev.2021.02.015CrossRefGoogle ScholarPubMed
Viviani, G and Vallesi, A (2021) EEG-neurofeedback and executive function enhancement in healthy adults: A systematic review. Psychophysiology 58(9), . doi:10.1111/psyp.13874Google Scholar
Wool, MS and Mor, V (2005) A multidimensional model for understanding cancer pain. Cancer Investigation 23(8), 727734. doi:10.1080/07357900500360032Google Scholar
Zaza, C and Baine, N (2002) Cancer pain and psychosocial factors: A critical review of the literature. Journal of Pain and Symptom Management 24(5), 526542. doi:10.1016/S0885-3924(02)00497-9CrossRefGoogle ScholarPubMed
Supplementary material: File

Rolbiecki et al. supplementary material

Rolbiecki et al. supplementary material
Download Rolbiecki et al. supplementary material(File)
File 16.7 KB